All In Biotech

Drug Trial Radar · NCT02959983

Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use

A Phase 4 Multicenter, Multinational, Prospective, Randomized, Placebo-Controlled, Double-Blinded Parallel Group Study to Assess Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D) in Patients Who Report Inadequate Control of IBS-D Symptoms With Prior Loperamide Use (RELIEF)

Last checked: Nov 20, 2026Latest source record: Feb 15, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 346 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

346

Actual

Start

Oct 25, 2016

Primary completion

Jan 22, 2018

Study completion Jan 22, 2018

Sponsor

Lead sponsor
AllerganAbbVie (ABBV)
Sponsor type
Industry
First posted
Nov 9, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the efficacy and safety of eluxadoline 100 milligrams (mg) twice a day (BID) versus placebo for the treatment of patients with Irritable Bowel Syndrome with Diarrhea (IBS-D) who report that the use of loperamide in the prior 12 months failed to provide control of their IBS-D symptoms.

Conditions

  • Irritable Bowel Syndrome With Diarrhea

Interventions

  • EluxadolineDrug

    Eluxadoline 100 mg oral tablets BID with food.

  • PlaceboDrug

    Placebo matching eluxadoline oral tablets BID with food.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Who Were Composite Responders Based on Improvements From Baseline in Daily Worst Abdominal Pain And Daily Stool Consistency ScoresTime frame: Baseline, Weeks 1 to 12

Locations

83 sites in 2 countries. Site status is shown where the registry gives one.

  • Clinical Research Associates, LLC

    Huntsville, Alabama

  • The Center for Clinical Trials

    Saraland, Alabama

  • Elite Clinical Studies

    Phoenix, Arizona

  • Arkansas Gastroenterology

    North Little Rock, Arkansas

  • Med Investigations

    Carmichael, California

  • GW Research Inc

    Chula Vista, California

  • Diagnamics Inc

    Encinitas, California

  • Behavioral Research Specialists, LLC

    Irvine, California

  • Providence Clinical Research

    North Hollywood, California

  • Shahram Jacobs MD INC.

    Sherman Oaks, California

  • Westlake Medical Research

    Thousand Oaks, California

  • Upland Clinical Research

    Upland, California

  • Advanced RX Clinicial Research Group, Inc.

    Westminster, California

  • Connecticut Clinical Research Foundation

    Bristol, Connecticut

  • Medical Research Center of Connecticut, LLC

    Hamden, Connecticut

  • Innovative Research of West Florida, Inc.

    Clearwater, Florida

  • Digestive Care of N. Broward

    Coral Springs, Florida

  • Homestead Medical Research

    Homestead, Florida

  • Clinical Neuroscience Solutions Inc.

    Jacksonville, Florida

  • Health Awareness, Inc.

    Jupiter, Florida

  • Precision Clinical Research LLC

    Lauderdale Lakes, Florida

  • Pharmax Research Clinic Inc.

    Miami, Florida

  • Well Pharma Medical Research, Corp.

    Miami, Florida

  • Ocean Blue Medical Research Center, Inc

    Miami Springs, Florida

  • Bravo Health Care Center

    North Bay Village, Florida

  • Clinical Neuroscience Solutions Inc.

    Orlando, Florida

  • Clinical Research of West Florida Inc.

    Tampa, Florida

  • Meridien Research

    Tampa, Florida

  • Emory University School of Medicine

    Atlanta, Georgia

  • RNA America, LLC

    Buford, Georgia

  • Northwestern University Feinbery School of Medicine

    Chicago, Illinois

  • Pharmakon Inc

    Evergreen Park, Illinois

  • Investigators Research

    Brownsburg, Indiana

  • Radiant Research, Inc.

    Evansville, Indiana

  • Clinical Research Advantage Inc/Radiant Research Inc.

    Evansville, Indiana

  • Gtc Research

    Shawnee Mission, Kansas

  • Investigative Clinical Research

    Annapolis, Maryland

  • MGG Group Co. Inc. Chevy Chase Clinical Research

    Chevy Chase, Maryland

  • MedVadis Research Corporation

    Watertown, Massachusetts

  • Clinical Research Insititute of Michigan LLC

    Chesterfield, Michigan

Showing 40 of 83 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.